Nano-titanium dioxide modulates the dermal sensitization potency of DNCB

Particle and Fibre Toxicology

Volumn 9, Issue , 2012, Pages

  Hussain, Salik ^a,b,c   Smulders, Stijn ^b   De Vooght, Vanessa ^b   Ectors, Bert ^b   Boland, Sonja ^a   Marano, Francelyne ^a   Van Landuyt, Kirsten L ^b   Nemery, Benoit ^b   Hoet, Peter H M ^b   Vanoirbeek, Jeroen A J ^b  

^a Groupe Hospitalier Pitié Salpêtrière   (France)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

DNCB; Lymph node proliferation assay (LNPA); Nanoparticle; Skin sensitization; Titanium dioxide (TiO2)

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ACETONE; CITRATE SODIUM; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; NANOCRYSTAL; NANOPARTICLE; OLIVE OIL; TITANIUM DIOXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; IMMUNOMODULATION; IMMUNOREACTIVITY; IN VIVO STUDY; LOCAL LYMPH NODE ASSAY; LYMPH NODE CELL; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NANOANALYSIS; NANOCHEMISTRY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN SENSITIZATION; TH2 CELL; ZETA POTENTIAL;

ADMINISTRATION, CUTANEOUS; ANIMALS; CELL PROLIFERATION; CYTOKINES; DINITROCHLOROBENZENE; EAR, EXTERNAL; IMMUNOLOGIC FACTORS; INJECTIONS, SUBCUTANEOUS; IRRITANTS; LYMPH NODES; LYMPHOCYTES; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; TITANIUM;

MUS;

EID: 84861331694     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/1743-8977-9-15     Document Type: Article

References (43)

1. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Wiesner MR, Nel AE. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 2006, 6:1794-1807. 10.1021/nl061025k, 16895376.
2. Kaida T, Kobayashi K, Adachi M, Suzuki F. Optical characteristics of titanium oxide interference film and the film laminated with oxides and their applications for cosmetics. J Cosmet Sci 2004, 55:219-220.
3. Long TC, Tajuba J, Sama P, Saleh N, Swartz C, Parker J, Hester S, Lowry GV, Veronesi B. Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro. Environ Health Perspect 2007, 115:1631-1637. 10.1289/ehp.10216, 2072833, 18007996.
4. Mani G, Johnson DM, Marton D, Feldman MD, Patel D, Ayon AA, Agrawal CM. Drug delivery from gold and titanium surfaces using self-assembled monolayers. Biomaterials 2008, 29:4561-4573. 10.1016/j.biomaterials.2008.08.014, 18790530.
5. Brien WW, Salvati EA, Betts F, Bullough P, Wright T, Rimnac C, Buly R, Garvin K. Metal levels in cemented total hip arthroplasty. A comparison of well-fixed and loose implants. Clin Orthop Relat Res 1992, 276:66-74.
6. Flatebo RS, Johannessen AC, Gronningsaeter AG, Boe OE, Gjerdet NR, Grung B, Leknes KN. Host response to titanium dental implant placement evaluated in a human oral model. J Periodontol 2006, 77:1201-1210. 10.1902/jop.2006.050406, 16805683.
7. Frisken KW, Dandie GW, Lugowski S, Jordan G. A study of titanium release into body organs following the insertion of single threaded screw implants into the mandibles of sheep. Aust Dent J 2002, 47:214-217. 10.1111/j.1834-7819.2002.tb00331.x, 12405460.
8. Torgersen S, Gjerdet NR, Erichsen ES, Bang G. Metal particles and tissue changes adjacent to miniplates. A retrieval study. Acta Odontol Scand 1995, 53:65-71.
9. Hoet PH, Bruske-Hohlfeld I, Salata OV. Nanoparticles - known and unknown health risks. J Nanobiotechnology 2004, 2:12. 10.1186/1477-3155-2-12, 544578, 15588280.
10. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdorster G, Philbert MA, Ryan J, Seaton A, Stone V, et al. Safe handling of nanotechnology. Nature 2006, 444:267-269. 10.1038/444267a, 17108940.
11. Lalko JF, Kimber I, Dearman RJ, Gerberick GF, Sarlo K, Api AM. Chemical reactivity measurements: potential for characterization of respiratory chemical allergens. Toxicol In Vitro 2011, 25:433-445. 10.1016/j.tiv.2010.11.007, 21092755.
12. van Loveren H, Cockshott A, Gebel T, Gundert-Remy U, de Jong WH, Matheson J, McGarry H, Musset L, Selgrade MK, Vickers C. Skin sensitization in chemical risk assessment: report of a WHO/IPCS international workshop focusing on dose-response assessment. Regul Toxicol Pharmacol 2008, 50:155-199. 10.1016/j.yrtph.2007.11.008, 18237832.
13. Garrigue JL, Nicolas JF, Fraginals R, Benezra C, Bour H, Schmitt D. Optimization of the mouse ear swelling test for in vivo and in vitro studies of weak contact sensitizers. Contact Dermatitis 1994, 30:231-237. 10.1111/j.1600-0536.1994.tb00650.x, 8033550.
14. Zhang EY, Chen AY, Zhu BT. Mechanism of dinitrochlorobenzene-induced dermatitis in mice: role of specific antibodies in pathogenesis. PLoS One 2009, 4:e7703. 10.1371/journal.pone.0007703, 2766640, 19890385.
15. Watanabe H, Unger M, Tuvel B, Wang B, Sauder DN. Contact hypersensitivity: the mechanism of immune responses and T cell balance. J Interferon Cytokine Res 2002, 22:407-412. 10.1089/10799900252952181, 12034022.
16. Kimber I, Hilton J, Weisenberger C. The murine local lymph node assay for identification of contact allergens: a preliminary evaluation of in situ measurement of lymphocyte proliferation. Contact Dermatitis 1989, 21:215-220. 10.1111/j.1600-0536.1989.tb03198.x, 2598647.
17. Dobrovolskaia MA, Germolec DR, Weaver JL. Evaluation of nanoparticle immunotoxicity. Nat Nanotechnol 2009, 4:411-414. 10.1038/nnano.2009.175, 19581891.
18. Weaver JL, Chapdelaine JM, Descotes J, Germolec D, Holsapple M, House R, Lebrec H, Meade J, Pieters R, Hastings KL, et al. Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with potential to cause immune-mediated drug reactions. J Immunotoxicol 2005, 2:11-20. 10.1080/15476910590930100, 18958655.
19. Simonsson C, Madsen JT, Graneli A, Andersen KE, Karlberg AT, Jonsson CA, Ericson MB. A study of the enhanced sensitizing capacity of a contact allergen in lipid vesicle formulations. Toxicol Appl Pharmacol 2011, 252:221-227. 10.1016/j.taap.2011.02.010, 21335022.
20. Madsen JT, Vogel S, Johansen JD, Andersen KE. Encapsulating contact allergens in liposomes, ethosomes, and polycaprolactone may affect their sensitizing properties. Cutan Ocul Toxicol 2011, 30:116-123. 10.3109/15569527.2010.540765, 21198410.
21. Madsen JT, Vogel S, Johansen JD, Sorensen JA, Andersen KE, Nielsen JB. Percutaneous penetration characteristics and release kinetics of contact allergens encapsulated in ethosomes. Cutan Ocul Toxicol 2011, 30:38-44. 10.3109/15569527.2010.521220, 21091289.
22. Schulz J, Hohenberg H, Pflucker F, Gartner E, Will T, Pfeiffer S, Wepf R, Wendel V, Gers-Barlag H, Wittern KP. Distribution of sunscreens on skin. Adv Drug Deliv Rev 2002, 54(Suppl 1):S157-S163.
23. Lademann J, Weigmann H, Rickmeyer C, Barthelmes H, Schaefer H, Mueller G, Sterry W. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol 1999, 12:247-256. 10.1159/000066249, 10461093.
24. Liang XJ, Chen C, Zhao Y, Jia L, Wang PC. Biopharmaceutics and therapeutic potential of engineered nanomaterials. Curr Drug Metab 2008, 9:697-709. 10.2174/138920008786049230, 2715162, 18855608.
25. Patlolla RR, Desai PR, Belay K, Singh MS. Translocation of cell penetrating peptide engrafted nanoparticles across skin layers. Biomaterials 2010, 31:5598-5607. 10.1016/j.biomaterials.2010.03.010, 2875303, 20413152.
26. Johnston HJ, Hutchison GR, Christensen FM, Peters S, Hankin S, Stone V. Identification of the mechanisms that drive the toxicity of TiO(2)particulates: the contribution of physicochemical characteristics. Part Fibre Toxicol 2009, 6:33. 10.1186/1743-8977-6-33, 2804608, 20017923.
27. Mortensen LJ, Oberdorster G, Pentland AP, Delouise LA. In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR. Nano Lett 2008, 8:2779-2787. 10.1021/nl801323y, 18687009.
28. Kambara T, Aihara M, Matsukura S, Sato I, Kubota Y, Hirasawa T, Ikezawa Z. Effects of photocatalytic agent on DS-Nh mice, developing atopic dermatitis-like eruption with an increase of Staphylococcus aureus. Int Arch Allergy Immunol 2006, 141:151-157. 10.1159/000094717, 16864994.
29. Yanagisawa R, Takano H, Inoue K, Koike E, Kamachi T, Sadakane K, Ichinose T. Titanium dioxide nanoparticles aggravate atopic dermatitis-like skin lesions in NC/Nga mice. Exp Biol Med (Maywood ) 2009, 234:314-322.
30. Hussain S, Vanoirbeek JA, Hoet PH. Interactions of nanomaterials with the immune system. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012, 4(2):169-83. 10.1002/wnan.166, 22144008.
31. Hussain S, Boland S, Baeza-Squiban A, Hamel R, Thomassen LC, Martens JA, Billon-Galland MA, Fleury-Feith J, Moisan F, Pairon JC, et al. Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount. Toxicology 2009, 260:142-149. 10.1016/j.tox.2009.04.001, 19464580.
32. Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol Lett 2007, 171:99-110. 10.1016/j.toxlet.2007.04.008, 17566673.
33. Larsen ST, Roursgaard M, Jensen KA, Nielsen GD. Nano titanium dioxide particles promote allergic sensitization and lung inflammation in mice. Basic Clin Pharmacol Toxicol 2010, 106:114-117. 10.1111/j.1742-7843.2009.00473.x, 2816362, 19874288.
34. Chan RC, Wang M, Li N, Yanagawa Y, Onoe K, Lee JJ, Nel AE. Pro-oxidative diesel exhaust particle chemicals inhibit LPS-induced dendritic cell responses involved in T-helper differentiation. J Allergy Clin Immunol 2006, 118:455-465. 10.1016/j.jaci.2006.06.006, 16890772.
35. Dearman RJ, Warbrick EV, Skinner R, Kimber I. Cytokine fingerprinting of chemical allergens: species comparisons and statistical analyses. Food Chem Toxicol 2002, 40:1881-1892. 10.1016/S0278-6915(02)00179-5, 12419703.
36. McGuirk P, Higgins SC, Mills KH. The role of regulatory T cells in respiratory infections and allergy and asthma. Curr Allergy Asthma Rep 2010, 10:21-28. 10.1007/s11882-009-0078-2, 20425510.
37. Takano H, Yoshikawa T, Ichinose T, Miyabara Y, Imaoka K, Sagai M. Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice. Am J Respir Crit Care Med 1997, 156:36-42.
38. Yanagisawa R, Takano H, Inoue KI, Ichinose T, Sadakane K, Yoshino S, Yamaki K, Yoshikawa T, Hayakawa K. Components of diesel exhaust particles differentially affect Th1/Th2 response in a murine model of allergic airway inflammation. Clin Exp Allergy 2006, 36:386-395. 10.1111/j.1365-2222.2006.02452.x, 16499651.
39. Inoue K, Koike E, Yanagisawa R, Hirano S, Nishikawa M, Takano H. Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model. Toxicol Appl Pharmacol 2009, 237:306-316. 10.1016/j.taap.2009.04.003, 19371758.
40. Inoue K, Yanagisawa R, Koike E, Nishikawa M, Takano H. Repeated pulmonary exposure to single-walled carbon nanotubes exacerbates allergic inflammation of the airway: Possible role of oxidative stress. Free Radic Biol Med 2010, 48:924-934. 10.1016/j.freeradbiomed.2010.01.013, 20093178.
41. Kimber I, Dearman RJ. What makes a chemical a respiratory sensitizer?. Curr Opin Allergy Clin Immunol 2005, 5:119-124. 10.1097/01.all.0000162302.82233.93, 15764900.
42. Vanoirbeek JA, Tarkowski M, Vanhooren HM, De Vooght V, Nemery B, Hoet PH. Validation of a mouse model of chemical-induced asthma using trimellitic anhydride, a respiratory sensitizer, and dinitrochlorobenzene, a dermal sensitizer. J Allergy Clin Immunol 2006, 117:1090-1097. 10.1016/j.jaci.2006.01.027, 16675337.
43. Hussain S, Vanoirbeek JA, Luyts K, De Vooght V, Verbeken E, Thomassen LC, Martens JA, Dinsdale D, Boland S, Marano F, et al. Lung exposure to nanoparticles modulates an asthmatic response in a mouse model. Eur Respir J 2011, 37:299-309. 10.1183/09031936.00168509, 20530043.